Shopping Cart
- Remove All
- Your shopping cart is currently empty
Anti-Phospho-EGF Receptor (Tyr1068) Antibody (4Z591) is a Rabbit antibody targeting Phospho-EGF Receptor (Tyr1068). Anti-Phospho-EGF Receptor (Tyr1068) Antibody (4Z591) can be used in WB.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
20 μL | $80 | 7-10 days | |
100 μL | $233 | 7-10 days |
Description | Anti-Phospho-EGF Receptor (Tyr1068) Antibody (4Z591) is a Rabbit antibody targeting Phospho-EGF Receptor (Tyr1068). Anti-Phospho-EGF Receptor (Tyr1068) Antibody (4Z591) can be used in WB. |
Alias | PIG61, NISBD2, mENA, HER-1, HER1, ERRP, ERBB-1, ERBB1, ERBB |
Ig Type | Monoclonal Rabbit IgG |
Clone | 4Z591 |
Reactivity | Human |
Verified Activity | 1. Western blot analysis of extracts from serum-starved Hela, untreated (-) or treated with EGF using Phospho-EGF Receptor (Tyr1068) rabbit monoclonal Antibody at 1:2000 dilution (upper), or Anti-EGFR Antibody, Rabbit Polyclonal at 1:2000 dilution (lower). 2. Western blot analysis of extracts from serum-starved Hela, treated with EGF (10 ng/mL, 30 min), using Phospho-EGF Receptor (Tyr1068) Antibody and other brands’ antibodies (company C) at dilution of 1:2000, 1:20000 and 1:200000. (Validation Experiment) 3. Western blot analysis of extracts from serum-starved Hela, untreated (line A); treated with EGF or antigen-specific phosphopeptide (line C) or antigen-specific peptide (line D) using Phospho-EGF Receptor (Tyr1068) rabbit monoclonal Antibody at 1:5000 dilution. (Validation Experiment) 4. Western blot analysis of extracts from serum-starved Hela, untreated (line A); treated with EGF using Phospho-EGF Receptor (Tyr1068) rabbit monoclonal Antibody at 1:5000 dilution. (Validation Experiment) |
Application | WB |
Recommended Dose | WB: 1:1000-1:10000 |
Antibody Type | Monoclonal |
Host Species | Rabbit |
Construction | This antibody was obtained from a rabbit immunized with a synthetic peptide corresponding to the residues around Tyr1068 of Human Phospho-EGF Receptor. |
Purification | Protein A |
Appearance | Liquid |
Formulation | 10 mM sodium HEPES, 150 mM NaCl, 100 μg/mL BSA, 50% glycerol, pH 7.5 |
Research Background | As a member of the epidermal growth factor receptor (EGFR) family, EGFR protein is type I transmembrane glycoprotein that binds a subset of EGF family ligands including EGF, amphiregulin, TGF-α, betacellulin, etc. EGFR protein plays a crucial role in signaling pathway in the regulation of cell proliferation, survival and differentiation. Binding of a ligand induces EGFR protein homo- or heterodimerization, the subsequent tyrosine autophosphorylation and initiates various down stream pathways (MAPK, PI3K/PKB and STAT). In addition, EGFR signaling also has been shown to exert action on carcinogenesis and disease progression, and thus EGFR protein is proposed as a target for cancer therapy currently.Cancer ImmunotherapyImmune CheckpointImmunotherapyTargeted Therapy |
Conjucates | Unconjugated |
Immunogen | A synthetic peptide corresponding to the residues around Tyr1068 of Human Phospho-EGF Receptor |
Antigen Species | Human |
Biology Area | Cancer Drug Targets, Receptor Tyrosine Kinases (RTKs) |
Stability & Storage | Store at 2°C-8°C for 1 month. Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. Preservative-Free. |
Transport | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.